Commercialization
Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazol
Pulmatrix
PR-M04-19-NI-023Apr 05, 2019
IND Approval
Pulmatrix Receives IND Approval for Pulmazole Phase 2 Clinical Study
Pulmatrix
PR-M02-19-NI-022Feb 11, 2019